{"DataElement":{"publicId":"2370","version":"3","preferredName":"Breast Tumor Pathologic T Stage","preferredDefinition":"extent of the primary tumor determined prior to treatment based on evidence obtained from pathological examination of a resected specimen that entails a resection of the primary tumor or biopsy adequate to evaluate the highest category.","longName":"BRST_TUMOR_P_T_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2189063","version":"1","preferredName":"Breast Tumor Pathologic T Stage","preferredDefinition":"Information related to pathologic T stage of a breast tumor.","longName":"BRST_TUMOR_P_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5DFF578-1762-4DFB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-07","modifiedBy":"TAYLORT","dateModified":"2017-11-17","changeDescription":"11/17/17 tt associated with CS/CSI. 9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018485","version":"1","preferredName":"Breast Tumor T Stage","preferredDefinition":"the T (tumor) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"BRST_TUMOR_T_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"12","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":"No evidence of primary tumor","ValueMeaning":{"publicId":"2559524","version":"1","preferredName":"No evidence of primary tumor","longName":"2559524","preferredDefinition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pT0 TNM Finding v6 and v7","conceptCode":"C60966","definition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B591-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2C6-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1","valueDescription":"TUMOR 2 CM OR LESS IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560324","version":"1","preferredName":"TUMOR 2 CM OR LESS IN GREATEST DIMENSION","longName":"2560324","preferredDefinition":"TUMOR 2 CM OR LESS IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2C8-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1a","valueDescription":"TUMOR MORE THAN 0.1 CM BUT NOT MORE THAN 0.5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560356","version":"1","preferredName":"TUMOR MORE THAN 0.1 CM BUT NOT MORE THAN 0.5 CM IN GREATEST DIMENSION","longName":"2560356","preferredDefinition":"TUMOR MORE THAN 0.1 CM BUT NOT MORE THAN 0.5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2CA-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1b","valueDescription":"TUMOR MORE THAN 0.5 CM BUT NOT MORE THAN 1 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2571751","version":"1","preferredName":"TUMOR MORE THAN 0.5 CM BUT NOT MORE THAN 1 CM IN GREATEST DIMENSION","longName":"2571751v1.00","preferredDefinition":"TUMOR MORE THAN 0.5 CM BUT NOT MORE THAN 1 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E554-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"MMADDINENI","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2CD-1023-E034-0003BA12F5E7","beginDate":"2004-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1c","valueDescription":"TUMOR MORE THAN 1 CM BUT NOT MORE THAN 2 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560358","version":"1","preferredName":"TUMOR MORE THAN 1 CM BUT NOT MORE THAN 2 CM IN GREATEST DIMENSION","longName":"2560358","preferredDefinition":"TUMOR MORE THAN 1 CM BUT NOT MORE THAN 2 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2D0-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1mic","valueDescription":"MICROINVASION 0.1 CM OR LESS IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2559213","version":"1","preferredName":"MICROINVASION 0.1 CM OR LESS IN GREATEST DIMENSION","longName":"2559213","preferredDefinition":"MICROINVASION 0.1 CM OR LESS IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B45A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A3070A-A5A0-0BFC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T2","valueDescription":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560359","version":"1","preferredName":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","longName":"2560359","preferredDefinition":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A3070A-A5A2-0BFC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T3","valueDescription":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560360","version":"1","preferredName":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","longName":"2560360","preferredDefinition":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A3070A-A5A4-0BFC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T4","valueDescription":"TUMOR OF ANY SIZE WITH DIRECT EXTENSION TO THE CHEST WALL AND/OR SKIN","ValueMeaning":{"publicId":"2560367","version":"1","preferredName":"TUMOR OF ANY SIZE WITH DIRECT EXTENSION TO THE CHEST WALL AND/OR SKIN","longName":"2560367","preferredDefinition":"TUMOR OF ANY SIZE WITH DIRECT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8DC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A3070A-A5A6-0BFC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T4a","valueDescription":"EXTENSION TO CHEST WALL","ValueMeaning":{"publicId":"2558757","version":"1","preferredName":"EXTENSION TO CHEST WALL","longName":"2558757","preferredDefinition":"EXTENSION TO CHEST WALL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B292-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A3070A-A5A9-0BFC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T4b","valueDescription":"EDEMA (INCLUDING PEAU D'ORANGE) OR ULCERATION OF THE SKIN OF THE BREAST OR SATELLITE SKIN NODULES CONFINED TO THE SAME BREAST","ValueMeaning":{"publicId":"2558711","version":"1","preferredName":"EDEMA (INCLUDING PEAU D'ORANGE) OR ULCERATION OF THE SKIN OF THE BREAST OR SATELLITE SKIN NODULES CONFINED TO THE SAME BREAST","longName":"2558711","preferredDefinition":"EDEMA (INCLUDING PEAU D'ORANGE) OR ULCERATION OF THE SKIN OF THE BREAST OR SATELLITE SKIN NODULES CONFINED TO THE SAME BREAST","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B264-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2D2-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T4c","valueDescription":"BOTH T4A AND T4B","ValueMeaning":{"publicId":"2558324","version":"1","preferredName":"BOTH T4A AND T4B","longName":"2558324","preferredDefinition":"BOTH T4A AND T4B","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0E1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2D4-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T4d","valueDescription":"Inflammatory Breast Carcinoma","ValueMeaning":{"publicId":"2558969","version":"1","preferredName":"Inflammatory Breast Carcinoma","longName":"2558969","preferredDefinition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Inflammatory Carcinoma","conceptCode":"C4001","definition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B366-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"TAYLORT","dateModified":"2017-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2D6-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"TX","valueDescription":"PRIMARY TUMOR CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559890","version":"1","preferredName":"PRIMARY TUMOR CANNOT BE ASSESSED","longName":"2559890","preferredDefinition":"PRIMARY TUMOR CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6FF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2D8-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Tis","valueDescription":"CARCINOMA IN SITU: INTRADUCTAL CARCINOMA, LOBULAR CARCINOMA IN SITU, OR PAGET'S DISEASE OF THE NIPPLE WITH NO TUMOR","ValueMeaning":{"publicId":"2558356","version":"1","preferredName":"CARCINOMA IN SITU: INTRADUCTAL CARCINOMA, LOBULAR CARCINOMA IN SITU, OR PAGET'S DISEASE OF THE NIPPLE WITH NO TUMOR","longName":"2558356","preferredDefinition":"CARCINOMA IN SITU: INTRADUCTAL CARCINOMA, LOBULAR CARCINOMA IN SITU, OR PAGET'S DISEASE OF THE NIPPLE WITH NO TUMOR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B101-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A1FFF0-F2DA-1023-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Tis (DCIS)","valueDescription":"Ductal carcinoma in situ","ValueMeaning":{"publicId":"2575870","version":"1","preferredName":"Ductal carcinoma in situ","longName":"2575870v1.00","preferredDefinition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F56B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03A91E33-1EDD-0E1A-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2006-11-09","deletedIndicator":"No"},{"value":"Tis (LCIS)","valueDescription":"Lobular carcinoma in situ","ValueMeaning":{"publicId":"2576314","version":"1","preferredName":"Lobular carcinoma in situ","longName":"2576314v1.00","preferredDefinition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F727-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03A91E33-1EE1-0E1A-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"Tis (Paget's)","valueDescription":"Paget's disease of the nipple with no tumor.  [Note: Paget's disease associated with a tumor is classified according to the size of the tumor.]","ValueMeaning":{"publicId":"2576655","version":"1","preferredName":"Paget's disease of the nipple with no tumor.  [Note: Paget's disease associated with a tumor is classified according to the size of the tumor.]","longName":"2576655","preferredDefinition":"Paget's disease of the nipple with no tumor.  [Note: Paget's disease associated with a tumor is classified according to the size of the tumor.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F87C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03A91E33-1EE5-0E1A-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"T1d","valueDescription":"T1d","ValueMeaning":{"publicId":"4115576","version":"1","preferredName":"T1d","longName":"4115576","preferredDefinition":"T1d","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0F6AB3E-A6C9-4BFC-E040-BB89AD433675","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0F6AB3E-A6E2-4BFC-E040-BB89AD433675","beginDate":"2014-01-27","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","deletedIndicator":"No"},{"value":"Tmi","valueDescription":"Tmi","ValueMeaning":{"publicId":"5053773","version":"1","preferredName":"Tmi","longName":"5053773","preferredDefinition":"Tmi","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"254EE31D-73B5-FBFC-E050-BB89AD43738E","latestVersionIndicator":"Yes","beginDate":"2015-11-24","endDate":null,"createdBy":"BRETTS","dateCreated":"2015-11-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"254EE31D-73CE-FBFC-E050-BB89AD43738E","beginDate":"2015-11-24","endDate":null,"createdBy":"BRETTS","dateCreated":"2015-11-24","modifiedBy":"ONEDATA","dateModified":"2015-11-24","deletedIndicator":"No"},{"value":"T1mi","valueDescription":"T1mi","ValueMeaning":{"publicId":"5269991","version":"1","preferredName":"T1mi","longName":"5269991","preferredDefinition":"T1mi","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"330CBD92-EA59-0344-E050-BB89AD435054","latestVersionIndicator":"Yes","beginDate":"2016-05-17","endDate":null,"createdBy":"BRETTS","dateCreated":"2016-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"330CBD92-EA72-0344-E050-BB89AD435054","beginDate":"2016-05-17","endDate":null,"createdBy":"BRETTS","dateCreated":"2016-05-17","modifiedBy":"ONEDATA","dateModified":"2016-05-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4725D0F-6960-304F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-17","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-17","modifiedBy":"TAYLORT","dateModified":"2017-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811959","version":"1","longName":"Patient Char.","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811932","version":"1","longName":"Pathology Breast","context":"CTEP"},{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"},{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812723","version":"1","longName":"ThermoDox Study","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812732","version":"1","longName":"FES Study","context":"NCIP"}]},{"publicId":"2548333","version":"1","longName":"I-SPY","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812254","version":"1","longName":"C911/C1000","context":"NCIP"}]},{"publicId":"2716207","version":"1","longName":"ASCO (American Society of Clinical Oncology)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812713","version":"1","longName":"Breast Cancer Adjuvant Treatment","context":"NCIP"}]},{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"}]},{"publicId":"3886755","version":"1","longName":"Preoperative Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902140","version":"1","longName":"Preoperative","context":"BOLD"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171062","version":"1","longName":"RTOG-1005","context":"NRG"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"BOLD","type":"USED_BY","context":"BOLD"},{"name":"BRST_TUMOR_P_T_ST","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"COMMENT_168","type":"COMMENT","description":"Note: The AJCC staging version to use is protocol specific.","url":null,"context":"CTEP"},{"name":"Pathologic T Stage","type":"Preferred Question Text","description":"Pathologic T Stage","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"T Stage, Pathologic","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B47441E8-927A-343B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-17","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-17","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeDescription":"Modified registration status and removed from data standards CS/CSI. mc 4/6/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}